Intangible Assets

Learning Objectives

• Classify intangible assets as finite-lived, indefinite-lived, or goodwill and explain the accounting consequences of each
• Apply the two-step impairment model for finite-lived intangibles under ASC 360
• Apply the one-step impairment model for indefinite-lived intangibles and the goodwill impairment test under ASC 350
• Account for internally developed intangible assets and R&D costs under U.S. GAAP
• Distinguish between GAAP and IFRS treatment of development costs
• Prepare journal entries for acquisition, amortization, impairment, and disposal of intangible assets

The Core Idea: The Useful Life Question Controls Everything

Intangible assets present a deceptively simple routing problem. The accounting for any intangible — from a patent to a broadcast license to goodwill — is determined by the answer to a single question: can you estimate when this asset will stop generating economic benefits?

If you can, the asset has a finite life. You amortize it. You test for impairment only when something goes wrong (triggering events). The impairment test is the familiar two-step model from ASC 360 — the same model used for PP&E.

If you cannot, the asset has an indefinite life. You never amortize it. Instead, you test for impairment every year, whether or not something has gone wrong. The test is simpler — a direct comparison of fair value to carrying amount — because there are no future cash flow projections to use as a screening step.

Goodwill is a special case of indefinite life. It follows its own impairment rules at the reporting unit level, not the individual asset level. And it can only arise from an acquisition — you cannot create goodwill internally.

That is the entire architecture. The concept map below shows how these three categories relate:

Finite-Lived Intangible Assets

Finite-lived intangibles have a determinable useful life. They are amortized over that life, typically using the straight-line method unless another pattern better reflects the consumption of economic benefits.

Common Examples

Amortization

Journal entry — annual amortization of a patent:

Or, alternatively, credit the intangible asset directly (both methods are acceptable under GAAP):

Worked example: A company acquires a patent for $480,000 with an estimated useful life of 8 years and no residual value.

Annual amortization: $480,000 / 8 = $60,000

After 3 years, carrying amount: $480,000 − (3 × $60,000) = $300,000

Impairment of Finite-Lived Intangibles (ASC 360)

Finite-lived intangibles follow the same two-step impairment model as PP&E:

Step 1 — Recoverability test: Compare the asset's carrying amount to the sum of its undiscounted future cash flows.

• If undiscounted cash flows ≥ carrying amount → no impairment. Stop here.
• If undiscounted cash flows < carrying amount → proceed to Step 2.

Step 2 — Measurement: Impairment loss = Carrying amount − Fair value.

The undiscounted cash flow test in Step 1 is a screening filter. It is deliberately generous — undiscounted cash flows will always be higher than a present value calculation. An asset must fail this easy test before you measure the actual loss. This prevents unnecessary write-downs from modest declines.

Worked example: A customer relationship has a carrying amount of $200,000. Expected undiscounted future cash flows: $180,000. Fair value: $150,000.

• Step 1: $180,000 < $200,000 → impaired
• Step 2: Impairment loss = $200,000 − $150,000 = $50,000

The new carrying amount ($150,000) becomes the basis for future amortization. The impairment loss cannot be reversed under U.S. GAAP.

Triggering events — only test when events indicate impairment may exist: significant adverse change in business climate, legal factors, loss of a key customer, technology obsolescence, or a significant decline in market price. No annual testing required for finite-lived assets.

Indefinite-Lived Intangible Assets

Indefinite-lived intangibles have no foreseeable limit on their cash-flow-generating period. They are never amortized but are tested for impairment at least annually. Common examples include trade names, FCC broadcast licenses, and certain perpetual franchise rights.

"Indefinite" does not mean "infinite." The classification is reassessed each reporting period. If circumstances change and a useful life becomes determinable, the entity begins amortizing the asset prospectively.

Impairment Test

The impairment test for indefinite-lived intangibles is simpler than the two-step model for finite-lived assets. It is a one-step comparison: fair value vs. carrying amount.

• Fair value ≥ carrying amount → no impairment
• Fair value < carrying amount → impairment loss = carrying amount − fair value

There is no undiscounted cash flow screening step. The rationale: since the asset is not being amortized, GAAP requires a more frequent and direct check on value.

Optional qualitative assessment (Step 0): Before performing the quantitative test, the entity may assess qualitative factors to determine whether it is more likely than not (>50%) that fair value is less than carrying amount. If the answer is no, the quantitative test can be skipped.

Worked Example

A broadcast license has a carrying amount of $1,200,000. At the annual impairment date, the license's fair value is determined to be $1,050,000.

• Impairment loss: $1,200,000 − $1,050,000 = $150,000

New carrying amount: $1,050,000. This loss is not reversible.

Goodwill

Goodwill is the residual intangible — the amount paid in a business combination that cannot be attributed to any identifiable asset. It represents the excess of the purchase price over the fair value of identifiable net assets acquired.

Goodwill = Purchase Price − Fair Value of Net Identifiable Assets

Key Properties

• Goodwill arises only through a business combination — it cannot be internally generated
• Public entities: never amortized; private entities may elect to amortize over 10 years or less (ASU 2014-02)
• Assigned to reporting units for impairment testing
• Tested for impairment annually or more frequently if triggering events occur

Goodwill Impairment Test (ASC 350)

The current test is a one-step quantitative approach:

1. Compare the fair value of the reporting unit to its carrying amount (including goodwill)
2. If carrying amount > fair value → impairment loss = the difference, capped at the amount of goodwill allocated to that unit

The cap is critical: goodwill impairment can never create a situation where the reporting unit's carrying amount falls below its fair value. The write-down stops at zero goodwill.

Optional Qualitative Assessment (Step 0)

Before the quantitative test, an entity may perform a qualitative assessment. Factors to evaluate:

• Macroeconomic conditions (recession, industry decline)
• Industry and market conditions (increased competition, regulatory changes)
• Cost factors (rising input costs)
• Overall financial performance (declining revenues, margins, cash flows)
• Entity-specific events (loss of key personnel, litigation, restructuring)
• Sustained decrease in share price

If the qualitative assessment concludes it is not more likely than not that fair value is less than carrying amount, no quantitative test is required.

Worked Example

Company A acquires Company B for $5,000,000. Fair value of identifiable net assets: $4,200,000.

• Goodwill recognized: $5,000,000 − $4,200,000 = $800,000

One year later, the reporting unit's carrying amount (including goodwill) is $4,800,000 and its fair value is $4,300,000.

• Impairment loss: $4,800,000 − $4,300,000 = $500,000
• This is less than the $800,000 of goodwill, so the full $500,000 is recognized
• Goodwill is written down to $300,000

Goodwill impairment losses can never be reversed under U.S. GAAP. Once written down, the new carrying amount is the baseline going forward.

Internally Developed Intangibles and R&D

Under U.S. GAAP, most research and development costs are expensed as incurred. This includes:

• Salaries of R&D personnel
• Materials consumed in R&D activities
• Depreciation on R&D equipment with no alternative future use
• Contract research services
• Allocable indirect costs of R&D

Exceptions

R&D equipment with alternative future use: If equipment acquired for R&D also has uses outside R&D, it is capitalized and depreciated normally. Only the depreciation during R&D use is charged to R&D expense.

In-process R&D acquired in a business combination (IPR&D): Capitalized as an indefinite-life intangible asset until the project is completed or abandoned. Upon completion, it becomes finite-lived and is amortized. If abandoned, it is written off entirely.

GAAP vs. IFRS Treatment of Development Costs

This is one of the most frequently tested international differences on FAR:

IAS 38 capitalization criteria (all must be met):

1. Technical feasibility of completing the asset
2. Intention to complete and use or sell it
3. Ability to use or sell it
4. Probable future economic benefits
5. Availability of resources to complete it
6. Ability to reliably measure development expenditures

Under GAAP, you always expense R&D (with the software exception). Under IFRS, development costs meeting all six criteria must be capitalized. The philosophical difference is real: GAAP prioritizes reliability (expense because measurement is uncertain), while IFRS prioritizes relevance (capitalize because the asset has probable future benefits).

Other Internally Generated Intangibles

Internally developed brands, customer lists, mastheads, and similar items are always expensed as incurred under U.S. GAAP. They cannot be capitalized regardless of their value.

The Complete Reference

Key Exam Tips

1. Finite vs. indefinite determines amortization — finite-lived assets are amortized; indefinite-lived assets are not
2. Different impairment models — finite-lived uses the two-step ASC 360 model (undiscounted CF screen, then FV); indefinite-lived and goodwill use a one-step FV comparison
3. Goodwill impairment is capped — the loss cannot exceed the carrying amount of goodwill assigned to that reporting unit
4. No reversal of impairment — under U.S. GAAP, impairment losses on intangible assets (finite, indefinite, or goodwill) are permanent
5. IPR&D from acquisitions is capitalized — as an indefinite-lived asset until completed or abandoned
6. GAAP vs. IFRS on development costs — GAAP expenses; IFRS capitalizes if six criteria are met
7. Step 0 is optional — both indefinite-lived and goodwill impairment tests allow a qualitative screening before the quantitative test